<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1366955</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Single-cell RNA sequencing reveals Immune Education promotes T cell survival in mice subjected to the cecal ligation and puncture sepsis model</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ham</surname>
<given-names>Steven D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2378186"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abraham</surname>
<given-names>Mabel N.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1046292"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deutschman</surname>
<given-names>Clifford S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/822078"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Taylor</surname>
<given-names>Matthew D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/805898"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Division of Critical Care Medicine, Department of Pediatrics, Cohen Children&#x2019;s Medical Center/Northwell Health</institution>, <addr-line>New Hyde Park, NY</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Sepsis Research Laboratory, The Feinstein Institutes for Medical Research</institution>, <addr-line>Manhasset, NY</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Philip Alexander Efron, University of Florida, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Fei Qin, National Cancer Institute (NIH), United States</p>
<p>Vanessa Nomellini, University of Texas Southwestern Medical Center, United States</p>
<p>John Lyons, Emory University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Matthew D. Taylor, <email xlink:href="mailto:mtaylor15@northwell.edu">mtaylor15@northwell.edu</email>
</p>
</fn>
<fn fn-type="other" id="fn004">
<p>&#x2020;ORCID: Matthew D. Taylor, <uri xlink:href="https://orcid.org/0000-0003-2643-3050">orcid.org/0000-0003-2643-3050</uri>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1366955</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Ham, Abraham, Deutschman and Taylor</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Ham, Abraham, Deutschman and Taylor</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Individual T cell responses vary significantly based on the microenvironment present at the time of immune response and on prior induced T cell memory. While the cecal ligation and puncture (CLP) model is the most commonly used murine sepsis model, the contribution of diverse T cell responses has not been explored. We defined T cell subset responses to CLP using single-cell RNA sequencing and examined the effects of prior induced T cell memory (Immune Education) on these responses. We hypothesized that Immune Education prior to CLP would alter T cell responses at the single cell level at a single, early post-CLP time point.</p>
</sec>
<sec>
<title>Methods</title>
<p>Splenic T cells were isolated from C57BL/6 mice. Four cohorts were studied: Control, Immune-Educated, CLP, and Immune-Educated CLP. At age 8 weeks, Immune-Educated and Immune-Educated CLP mice received anti-CD3&#x3f5; antibody; Control and CLP mice were administered an isotype control. CLP (two punctures with a 22-gauge needle) was performed at 12-13 weeks of life. Mice were sacrificed at baseline or 24-hours post-CLP. Unsupervised clustering of the transcriptome library identified six distinct T cell subsets: quiescent na&#xef;ve CD4<sup>+</sup>, primed na&#xef;ve CD4<sup>+</sup>, memory CD4<sup>+</sup>, na&#xef;ve CD8<sup>+</sup>, activated CD8<sup>+</sup>, and CD8<sup>+</sup> cytotoxic T cell subsets. T cell subset specific gene set enrichment analysis and Hurdle analysis for differentially expressed genes (DEGs) were performed.</p>
</sec>
<sec>
<title>Results</title>
<p>T cell responses to CLP were not uniform &#x2013; subsets of activated and suppressed T cells were identified. Immune Education augmented specific T cell subsets and led to genomic signatures favoring T cell survival in unoperated and CLP mice. Additionally, the combination of Immune Education and CLP effected the expression of genes related to T cell activity in ways that differed from CLP alone. Validating our finding that IL7R pathway markers were upregulated in Immune-Educated CLP mice, we found that Immune Education increased T cell surface IL7R expression in post-CLP mice.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Immune Education enhanced the expression of genes associated with T cell survival in unoperated and CLP mice. Induction of memory T cell compartments via Immune Education combined with CLP may increase the model&#x2019;s concordance to human sepsis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cecal ligation and puncture</kwd>
<kwd>mouse sepsis model</kwd>
<kwd>sepsis</kwd>
<kwd>T cell</kwd>
<kwd>CD4</kwd>
<kwd>CD8</kwd>
<kwd>T cell activation</kwd>
<kwd>T cell memory</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="100"/>
<page-count count="18"/>
<word-count count="9567"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Inflammation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (<xref ref-type="bibr" rid="B1">1</xref>). The disorder affects nearly 50 million people annually, and it is a leading cause of in-hospital mortality and critical illness globally (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Moreover, it has been suggested that many sepsis-associated deaths are not preventable with current hospital-based care measures (<xref ref-type="bibr" rid="B4">4</xref>). This concern underscores the need for innovative sepsis research and novel therapeutic approaches.</p>
<p>Because of its biologic complexity sepsis is best studied <italic>in vivo</italic>, often using animal models. The cecal ligation and puncture (CLP) model is the most commonly used animal model of sepsis because it closely mimics the hemodynamic and metabolic phases of human sepsis (<xref ref-type="bibr" rid="B5">5</xref>). However, recent studies comparing laboratory mice kept in specific pathogen-free facilities to mice from &#x201c;natural&#x201d; environments have led to findings that may significantly affect the CLP model. These studies demonstrated that laboratory mice with limited antigenic exposure lack diverse memory T cell compartments (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). We have previously shown that administration of exogenous anti-CD3&#x3f5; antibody, a process herein termed Immune Education, to induce T cell memory before subjecting mice to CLP enhanced innate and adaptive immune responses, organ dysfunction, and mortality (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>CD3, which consists of four chains (CD3&#x3b3;, CD3&#x3b4;, and 2 CD3&#x3f5; chains), is a T cell coreceptor that complexes with the T cell receptor (TCR) during early T cell activation (<xref ref-type="bibr" rid="B11">11</xref>). Prior <italic>in vitro</italic> studies have shown that the Armenian hamster monoclonal antibody clone 145-2C11 targeting CD3&#x3f5; can be used to prime T cells and induce memory T cell responses that are indistinguishable from peptide-primed memory T cells (<xref ref-type="bibr" rid="B12">12</xref>). Our prior work demonstrated that Immune Education can be used to induce polyclonal CD4 and CD8 T cell memory populations to partly address the lack of a cadre of memory T cells in CLP (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). In brief, the proportion of CD4 and CD8 memory T cells in spleen, lung, and liver were increased 35 days following a single intravenous administration of a moderate dose of anti- CD3&#x3f5; treatment. T cell memory phenotypes in these mice persisted for up to almost six months. These findings suggest that Immune Education induces heterogenous memory T cell development (<xref ref-type="bibr" rid="B9">9</xref>). T cell memory induction through Immune Education thus increased the fidelity of CLP as a model of human sepsis while providing a tool for studying the impact of T cell memory on CLP and, conversely, the effects of CLP on T cell memory responses. Using induced T cell memory via Immune Education allows for examination of the effect of CLP on specific T cell subsets that were previously lacking in laboratory mice. Moreover, induced T cell memory may permit the study of T cell responses to specific cytokine receptor signaling pathways after CLP. The IL7 receptor (IL7R) pathway is of particular interest given its roles in na&#xef;ve T cell survival and effector to memory T cell transition (<xref ref-type="bibr" rid="B13">13</xref>). Because of these functions, there have been trials investigating the therapeutic potential of IL7 in human sepsis (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Our study utilized single-cell RNA sequencing (scRNA-seq), which has been crucial to elucidating the heterogeneity of the full T cell repertoire (<xref ref-type="bibr" rid="B15">15</xref>). T cells have the ability to differentiate from na&#xef;ve T cells into memory T cells upon initial antigen exposure and following differentiation gain different functional properties that can drive immune responses. Further, T cells can &#x201c;remember&#x201d; the cytokine response during prior infection and will produce a more tailored response on repeat exposure. Many different T cell responses have been described in the literature: CD4 T cells can produce Th1, Th2, Th17, Th22, Th23, T follicular helper, and T<sub>reg</sub> responses while CD8 T cells have been shown to respond with a Tc1 or Tc2 phenotype (<xref ref-type="bibr" rid="B16">16</xref>). There are likely other T cell responses that have not yet been defined as well. Given the immense complexity and plasticity of individual T cell responses during an immune response, scRNA-seq has helped elucidate gene expression patterns across T cell subsets and disease states unable to be captured by &#x201c;bulk&#x201d; sequencing approaches (<xref ref-type="bibr" rid="B17">17</xref>). We used scRNA-seq to examine T cell subset specific responses to CLP, and specifically interrogated the effects of prior induced T cell memory via Immune Education on these responses.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Mice</title>
<p>All studies were approved by the Institutional Animal Care and Use Committee (IACUC #2017-039) and adhered to National Institutes of Health and Animal Research: Reporting of <italic>In Vivo</italic> Experiments (ARRIVE) guidelines. C57BL/6J mice were obtained from The Jackson Laboratory (Bay Harbor, ME) and maintained at the animal facility of the Feinstein Institute for Medical Research. We used only male mice in this study for three reasons: 1) previous studies indicated that mortality from CLP is higher in male mice; 2) because the differences in mortality reflect, in part, a protective effect from estrogen, responses in female mice are subject to variability secondary to the estrous cycle; and 3) most of the vast literature on CLP has been generated using male mice only, making comparisons with female mice problematic (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). The mice used for scRNA-seq were split into four cohorts: Control, Immune-Educated, CLP, and Immune-Educated CLP (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Workflow illustrating mouse cohorts, splenic T cell isolation by negative selection and cell sorting, and single-cell capture via 10x Genomics Chromium Next GEM (gel beds-in-emulsion) prior to sequencing. After unsupervised clustering to identify distinct T cell subsets, cell subset specific analysis was performed with KEGG gene set enrichment analysis and Hurdle analysis to identify differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>
<italic>In vivo</italic> immune education</title>
<p>Immune Education was performed as previously described (<xref ref-type="bibr" rid="B8">8</xref>). Briefly, Ultra-LEAF anti-mouse CD3&#x3f5; antibody (145-2C11, BioLegend, San Diego, CA; 50 &#x3bc;g in 200 &#x3bc;L sterile phosphate-buffered saline) was administered via retro-orbital venous sinus injection to 8-week-old mice (<xref ref-type="bibr" rid="B9">9</xref>). Thirty-five days later, this approach had increased the total number and fraction of splenic memory (CD44<sup>+</sup>/CD11a<sup>+</sup>) T cells in both CD4 and CD8 subpopulations (<xref ref-type="bibr" rid="B9">9</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Cecal ligation and puncture procedure</title>
<p>Mice were subjected to CLP with two 22-gauge punctures under isoflurane anesthesia as previously described (<xref ref-type="bibr" rid="B20">20</xref>). All mice that underwent CLP were approximately 12-13 weeks of age. Animals were resuscitated with 50 mL/kg sterile saline immediately after surgery through subcutaneous tissue injection. CLP and Immune-Educated CLP mice were euthanized at a single, early post-CLP time point (24-hours after CLP). Antibiotics were not administered because of studies indicating that they alter the early immune responses to CLP (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Access to food and water was identical for all animals.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Leukocyte isolation</title>
<p>All mice were euthanized either at baseline (Control, Immune-Educated) or at 24 hours post-CLP (CLP, Immune-Educated CLP), at which time spleens were harvested. Single cell suspensions were prepared, and the T cells were sorted by negative selection using a validated pan-T cell isolation kit (Miltenyi Biotec). This technique selects a population of cells that are approximately 90% T cells. The population was increased to approximately 97% purity using fluorescence-assisted cell sorting (BD FACSAria&#x2122; III Cell Sorter, San Jose, CA) for live, singlet, CD90<sup>+</sup> cells to ensure that primarily CD4 and CD8 T cells were analyzed.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>10x Genomics single-cell sample processing and RNA sequencing</title>
<p>Libraries were prepared using the 10x Genomics Chromium Next GEM (gel beds-in-emulsion) Single Cell 3&#x2019; Reagent Kit per the manufacturer&#x2019;s instructions. The splenic T cells were loaded on a Chromium Next GEM Chip and then applied to the Chromium Controller, which performed single cell partitioning into the nanoliter-scale GEMs. Each GEM contained an identifying barcode for downstream single cell analysis. These sample libraries were then sequenced using an Illumina Novaseq System following the 10x Genomics next-generation sequencing specifications.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Processing, dimensionality reduction, and clustering of scRNA-seq data</title>
<p>Cell Ranger analysis pipelines were used to demultiplex the raw scRNA-seq data and align it to the reference <italic>Mus musculus</italic> genome (GRCm38). Data files were then uploaded to Partek&#xae; Flow&#xae;, a cloud-based genomic analysis platform, for analysis. Quality control analysis was performed: cells with &lt;200 detected genes, &gt;5,000 detected genes, and &gt;8% mitochondrial genes were determined to be low quality cells (695 of 9,022 total cells) and filtered out (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>) (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Features not expressed in at least 99.9% of cells (5,903 of 20,085 total genes) and ribosomal features (101 genes of 20,085 total genes) were filtered out prior to normalization. Primary component analysis (PCA) was used for initial dimensionality reduction. Graph based clustering with the top 20 primary components (PCs) was performed using a Louvain algorithm and resolution of 1.0. Graph based clusters were then used to define cell populations on Uniform Manifold Approximation and Projection (UMAP) plots. GraphPad Prism 10 was used to perform two-way ANOVA and multiple comparisons testing with &#x160;&#xed;d&#xe1;k correction to compare cell counts in T cell subsets across the experimental conditions.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Gene set enrichment and differential gene expression analyses</title>
<p>Gene set enrichment analysis (GSEA) analyzes sequencing data by determining if there are statistically significant differences in the expression of predefined gene sets between two biologic phenotypes. GSEA was used to identify altered biochemical pathways as described in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. This compendium includes manually created pathways derived from published literature to depict molecular interactions (<xref ref-type="bibr" rid="B25">25</xref>). Pathways were considered significant at a false discovery rate (FDR) &#x2264;0.25 and P-value &#x2264;0.05. Cytoscape v3.10.1 was used to perform network analysis (<xref ref-type="bibr" rid="B26">26</xref>). Additionally, hurdle model analyses were performed on the top 2,000 features with highest variance to identify differentially expressed genes (DEGs) in each T cell subset (<xref ref-type="bibr" rid="B27">27</xref>). The hurdle model is widely used for scRNA-seq analysis because it accounts for zero inflation (a distribution where there are frequent zero counts i.e., cells not expressing a certain gene), which is commonly seen with scRNA-seq data (<xref ref-type="bibr" rid="B28">28</xref>). Statistical significance for DEGs, genes with differences in read counts between two experimental conditions, was defined by P-value &#x2264;0.01 and fold change of &lt;-2 or &gt;2.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Flow cytometry analysis</title>
<p>Flow cytometry was performed on a BD LSR Fortessa 16-color cell analyzer or a BioRad ZE5 16-color analyzer and analyzed using FlowJo software version 10 (BD Bioscience, San Jose, CA). Staining was performed with the following antibodies: CD90.2, CD8a, CD4, and CD127.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Identification of six distinct T cell subsets via unsupervised cluster analysis of the single cell RNA sequencing library</title>
<p>Our scRNA-seq library consisted of 9,022 single cells and 20,097 total features from the 12 samples. Following data quality checks our library consisted of 14,081 features from 8,327 high quality cells. Cells that highly expressed pro-B cell markers (82 cells), NK cell markers (431 cells), and lncRNAs (1,188 cells) were filtered out. Additionally, <italic>Cd3e <sup>&#x2013;</sup>
</italic> cells (668 cells) were also omitted leaving 5,958 <italic>Cd3e<sup>+</sup>
</italic> cells for final analysis. Control mice had 959 cells (median counts per cell 12,822), Immune-Educated mice had 2,052 cells (median counts per cell 12,857), CLP mice had 1,154 cells (median counts per cell 11,677), and Immune-Educated CLP mice had 1,793 cells (median counts per cell 11,966).</p>
<p>Cluster analysis on UMAP plot, using T cells from all treatment groups, revealed 6 distinct T cell subsets which were classified by canonical cell marker genes as seen in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>. The top 25 differentially expressed features in each cluster are listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. Clusters 1 and 2 (<italic>Cd3</italic>
<sup>+</sup>, <italic>Cd4</italic>
<sup>+</sup>, <italic>Zbtb7b</italic>
<sup>+</sup>) were identified as a na&#xef;ve CD4 subpopulation. Cluster 1 was noted to have increased <italic>Foxp1</italic> expression, a marker of CD4 T cell quiescence (<xref ref-type="bibr" rid="B29">29</xref>), when compared to cluster 2. Thus, cluster 1 was identified as quiescent na&#xef;ve CD4 T cells and cluster 2 was identified as primed na&#xef;ve CD4 T cells. Clusters 3 and 4 (<italic>Cd3</italic>
<sup>+</sup>, <italic>Cd8a</italic>
<sup>+</sup>, <italic>Cd8b</italic>
<sup>+</sup>, <italic>Runx3</italic>
<sup>+</sup>) were identified as CD8 T cells. Cluster 3 was noted to have higher expression of genes characteristic of na&#xef;ve CD8 T cells such as <italic>Ccr9</italic> (<xref ref-type="bibr" rid="B30">30</xref>). On the other hand, cluster 4 was consistent with an activated CD8 T cell population with higher fold levels of expression in genes such as <italic>Ccl5</italic> (<italic>Rantes</italic>) and <italic>Xcl1</italic> (<italic>Atac</italic>) (<xref ref-type="bibr" rid="B31">31</xref>). Cluster 5 was a very diverse cluster of memory CD4 T cells (<italic>Cd3</italic>
<sup>+</sup>, <italic>Cd4</italic>
<sup>+</sup>) including T<sub>reg</sub> (<italic>Foxp3</italic>
<sup>+</sup>), Th1 (<italic>Tbx21</italic>
<sup>+</sup>), Th2 (<italic>Gata3</italic>
<sup>+</sup>), and Th17 (<italic>Rorc</italic>
<sup>+</sup>) cells. Lastly, cluster 6 had <italic>Cd3</italic>
<sup>+</sup>, <italic>Cd4</italic>
<sup>-</sup>, <italic>Cd8a</italic>
<sup>lo</sup>, and <italic>Cd8b</italic>
<sup>lo</sup> T cells that expressed cytotoxic lymphocyte markers such as <italic>Eomes</italic>, which was consistent with a CD8 cytotoxic T cell population.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>After processing and normalizing the scRNA-seq library, dimensionality reduction was performed using PCA. <bold>(A)</bold> Following unsupervised graph based cluster analysis, UMAP plots were created to identify 6 distinct T cell subsets. <bold>(B)</bold> A bar graph was generated depicting the number of cells in each T cell subset. <bold>(C)</bold> Expression levels for genes of interest were visualized with UMAP. Genes included were markers for CD4 T cells (<italic>Cd4, Zbtb7b</italic>) and CD8 T cells (<italic>Cd8a, Cd8b1, Runx3</italic>), and those involved in the IL7R signaling pathway (<italic>ll7r, Pik3cd, Jak1, Stat3</italic>, and <italic>Bcl2</italic> family members). AUCell was performed using previously published gene signatures for <bold>(D)</bold> CD4 and <bold>(E)</bold> CD8 T cells. These results confirm appropriate clustering of CD4 and CD8 T cells based on previous results external to our dataset.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g002.tif"/>
</fig>
<p>The distribution of cells in each subset can be seen in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>. Distribution of genes involved in CD4-CD8 lineage differentiation and IL7 signaling for T cell survival/apoptosis were plotted on UMAP plots for visualization (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). AUCell, an analysis tool using &#x201c;Area Under the Curve&#x201d; (AUC) to calculate the enrichment of active gene sets, was performed to validate the identified T cell subsets from unsupervised clustering in our UMAP plots. AUCell results demonstrated whether CD4 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>) and CD8 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>) signatures from Chopp, et al. (<xref ref-type="bibr" rid="B32">32</xref>) were within the top 5% of ranked genes from each cell. These results confirm appropriate clustering of CD4 and CD8 T cells based on previous results external to our dataset.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Immune Education augments cell counts in na&#xef;ve CD4 T cell subsets</title>
<p>The UMAP plot from <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, depicting T cell subsets identified by unsupervised cluster analysis, was split by experimental group in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>. This allowed for visualization of T cell subset sizes across the treatment conditions. The cell counts within each T cell subset across experimental groups were graphed on box plots (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) with significance indicated based on results from two-way ANOVA and &#x160;&#xed;d&#xe1;k&#x2019;s multiple comparisons test.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<bold>(A)</bold> UMAP plots of cells in each of the experimental groups were created for visualization. <bold>(B)</bold> Cell counts within each T cell subset were then graphed on dot plots (Con=Control, Edu-Immune-Educated, CLP=CLP, and Edu+CLP=Immune-Educated CLP). Two-way ANOVA and &#x160;&#xed;d&#xe1;k&#x2019;s multiple comparisons test were performed to examine differences in T cell subset sizes across the experimental groups. Significance was indicated by asterisks, and significant P-values were listed under the plots. ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g003.tif"/>
</fig>
<p>In the quiescent na&#xef;ve CD4 T cell subset, Immune Education led to an increase in cell counts (P<sub>Edu</sub>=0.0023). For the cell counts in the primed na&#xef;ve CD4 T cell subset, both Immune Education (P<sub>Edu</sub>=0.0020) and CLP (P<sub>CLP</sub>=0.0036) led to statistically significant increases, but the interaction term was not statistically significant (P<sub>Int</sub>=0.8245).</p>
<p>In the activated CD8 T cell subset, the interaction term was statistically significant (P<sub>Int</sub>=0.0314) indicating that the effect of CLP differs in control and Immune-Educated mice. Immune-Educated mice had significantly more activated CD8 T cells than Immune-Educated CLP (P=0.0124) mice. The interaction term was also significant on analysis of cell counts in the memory CD4 T cell subset (P<sub>Int</sub>=0.0357). In the memory CD4 T cell subset, Immune-Educated mice had more memory CD4 T cells when compared to Control (P=0.0093); the number of memory CD4 T cells was lower following CLP in Immune Educated mice.</p>
<p>No statistically significant changes were noted in the na&#xef;ve CD8 and cytotoxic CD8 T cell subpopulations.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Genomic signatures of immune-educated mice favor T cell survival and clonal proliferation when compared to control mice</title>
<p>A list of all significant KEGG pathways&#x2014;manually created gene pathways depicting biological processes from published literature&#x2014;in Immune-Educated mice relative to Control mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>. A list of all significant DEGs&#x2014;genes that have differential read counts across two experimental conditions&#x2014; in Immune-Educated mice relative to Control mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>.</p>
<p>GSEA of na&#xef;ve CD4 T cells (clusters 1 and 2) showed no significant differences in KEGG pathways between Immune-Educated and Control mice. Hurdle analysis of quiescent na&#xef;ve CD4 T cells (cluster 1) identified 17 DEGs; following Immune Education, expression in 5 was upregulated while expression in 12 was downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Among the genes whose expression were affected by Immune Education were <italic>Il7r</italic> (downregulated 2.31 fold, P=0.0013) and <italic>Bcl2</italic> (B-cell lymphoma-2; upregulated 2.30 fold, P=0.0108), whose encoded protein limits apoptosis and enhances cell survival by promoting IL7 mediated processes (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). This may indicate IL7-mediated cell survival via Bcl2 in the quiescent na&#xef;ve CD4 T cells in Immune-Educated mice. Hurdle analysis of primed na&#xef;ve CD4 T cells (cluster 2) identified 23 DEGs; following Immune Education, expression in 14 was upregulated while expression in 9 was downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Among the genes whose expression were affected by Immune Education were <italic>Bcl2</italic> (upregulated 2.48 fold, P-value 0.0349) and <italic>Nfkbia</italic> (downregulated 3.05 fold, P=0.0086), whose protein I&#x3ba;B-&#x3b1; (inhibitor kappa B-alpha) inhibits NF-&#x3ba;B (nuclear factor kappa-light-chain-enhancer of activated B cells). It has been suggested that I&#x3ba;B-&#x3b1; mediated inhibition of NF-&#x3ba;B signaling impairs T cell proliferation (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). These results suggest enhanced cell survival in the primed na&#xef;ve CD4 T cell clusters following Immune Education. Additionally, the expression of <italic>Igfbp4</italic> (insulin-like growth factor binding protein 4; upregulated 2.87 fold, P=0.0034) was also affected by Immune Education in the primed na&#xef;ve CD4 T cell subset, which is notable since IGFBP-4 signaling has been associated with preferential CD4 effector Th17 differentiation (<xref ref-type="bibr" rid="B37">37</xref>). The importance of Th17 cells in host defense against pathogens, especially at mucosal surfaces, has been well established (<xref ref-type="bibr" rid="B38">38</xref>). Lastly, in primed na&#xef;ve CD4 T cells, Immune Education affected expression of <italic>Cd48</italic> (<italic>Slamf2</italic>; upregulated 2.78 fold, P=0.0033). Notably CD48, in conjunction with its ligand 2B4, has co-stimulatory functions during CD3-induced T cell proliferation, interacts with CD2 during T cell activation, and is upregulated during inflammation (<xref ref-type="bibr" rid="B39">39</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Differential gene expression by hurdle analysis was performed within each T cell subset to compare the effect of Immune-Education relative to Controls. Volcano plots were used to show the adjusted P values and log2 fold change values from these analyses. Red dots indicate upregulated genes, blue dots indicate downregulated genes, and gray dots represent insignificant or inconclusively different genes in Immune-Educated mice relative to Control mice. The top 5 upregulated and top 5 downregulated genes are labeled on the volcano plots. Results for <bold>(A)</bold> quiescent na&#xef;ve CD4, <bold>(B)</bold> primed na&#xef;ve CD4, <bold>(C)</bold> na&#xef;ve CD8, <bold>(D)</bold> activated CD8, <bold>(E)</bold> memory CD4, and <bold>(F)</bold> cytotoxic CD8 T cells are shown. The full list of DEGs can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>. Overlapping DEGs in the <bold>(G)</bold> CD4<sup>+</sup> subsets and <bold>(H)</bold> CD8<sup>+</sup> subsets were identified and depicted on Venn diagrams.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g004.tif"/>
</fig>
<p>In the na&#xef;ve CD8 T cell subset (cluster 3), a total of 65 KEGG pathways were upregulated in Immune-Educated mice when compared to Controls (there were no significantly downregulated pathways). Among the enriched gene sets following Immune Education was the JAK-STAT signaling pathway (NES 1.60) which is significant given its central role in cytokine responsiveness. As an example, IL15 has been shown to promote CD8 T cell proliferation by activating the JAK-STAT signaling pathway which upregulates Bcl-2 (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Hurdle analysis of na&#xef;ve CD8 T cells identified 27 DEGs; following Immune Education, expression in 21 was upregulated while expression in 6 was downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Among the impacted genes was <italic>Cd5</italic> (upregulated 2.42 fold, P=0.0002), which is notable because peripheral CD5<sup>hi</sup> na&#xef;ve CD8 T cells have been shown to undergo more efficient clonal recruitment and expansion in response to foreign antigens relative to CD5<sup>lo</sup> na&#xef;ve CD8 T cells (<xref ref-type="bibr" rid="B42">42</xref>). Moreover, CD5<sup>hi</sup> CD8 T cells have been shown to have higher propensity for self-reactivity (<xref ref-type="bibr" rid="B43">43</xref>). Additionally, expression of <italic>Cd7</italic> (upregulated 2.42 fold, P=0.0002) differed following Immune Education, which is notable given the costimulatory role of CD7 during TCR signaling (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Lastly, Immune Education affected expression of <italic>Nfkbia</italic> (downregulated 2.19 fold, P&lt;0.0001), which suggests increased CD8 T cell proliferation following Immune Education (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>Within the activated CD8 T cell subset (cluster 4), 7 KEGG pathways were upregulated in Immune-Educated mice when compared to Controls. Among the activated KEGG pathways following Immune Education was natural killer cell mediated cytotoxicity (NES 1.71), and this is noteworthy because memory CD8 T cells can gain NK-like functional responses (<xref ref-type="bibr" rid="B46">46</xref>). Hurdle analysis of activated CD8 T cells identified 27 DEGs; following Immune Education, expression in 10 was upregulated while expression in 17 was downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). Among the genes whose expression were affected by Immune Education were <italic>Klrc1</italic> (<italic>Nkg2a/b</italic>; upregulated 3.22 fold, P&lt;0.0001) and <italic>Klrk1</italic> (<italic>Nkg2d</italic>; upregulated 3.33 fold, P=0.0012), whose encoded proteins are members of the NKG2 (CD159) family of C-type lectin-like receptors. This is notable because these proteins complex with CD94 to form a heterodimer crucial to CD8 T cell survival and function (<xref ref-type="bibr" rid="B47">47</xref>&#x2013;<xref ref-type="bibr" rid="B49">49</xref>). In activated CD8 T cells, Immune Education also affected expression of <italic>Nfkbia</italic> (downregulated 2.07 fold, P=0.0013), a trend also observed in the na&#xef;ve CD8 T cell subset, indicating increased CD8 T cell proliferation after Immune Education (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>For memory CD4 T cells (cluster 5), GSEA showed 1 upregulated KEGG pathway after Immune Education, the alanine, aspartate, and glutamate metabolism pathway (NES 1.84). This may reflect the metabolic demands induced by differentiation of memory CD4 T cell into activated effector cells (<xref ref-type="bibr" rid="B50">50</xref>). Hurdle analysis of memory CD4 T cells identified 28 DEGs; following Immune Education, expression in 19 was upregulated while expression in 9 was downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). Among the genes whose expression were affected by Immune Education was <italic>Gadd45b</italic> (downregulated 2.20 fold, P&lt;0.0001), a member of the growth arrest and DNA damage (GADD)-inducible gene family. GADD45B enhances T cell survival by blocking Fas-induced apoptosis to inhibit activation induced cell death (AICD); however, <italic>Gadd45b</italic> mRNA expression in response to stimuli has previously been shown to rapidly peak and then decrease (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). This is notable given upregulation of <italic>Il18r1</italic> (upregulated 2.34 fold, P=0.0076) and <italic>Ifng</italic> (upregulated 2.02 fold, P=0.0159) following Immune Education because synergistic IL-12 and IL-18 induction of <italic>Gadd45b</italic>, independent of TCR signaling, has been shown to promote IFN-&#x3b3; production by Th1 T cells (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>The cytotoxic CD8 T cell subset (cluster 6) in Immune-Educated mice when compared to Controls had 21 upregulated KEGG pathways including antigen processing and presentation (NES 1.74) which is essential to the cytotoxic capacity of CD8 T cells (<xref ref-type="bibr" rid="B55">55</xref>). Hurdle analysis of cytotoxic CD8 T cells revealed 29 DEGs; following Immune Education, expression in 13 were upregulated while expression in 16 were downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). Among the genes whose expression were affected by Immune Education was <italic>Ilf2</italic> (<italic>Nf45</italic>; upregulated 4.42 fold, P=0.0048), whose encoded protein is part of the nuclear factor of activated T cells (NFAT) complex which acts as a transcription factor to induce T cell expression of various genes, including IL2 (<xref ref-type="bibr" rid="B56">56</xref>). Among the genes whose expression were downregulated following by Immune Education was <italic>Nkg7</italic> (downregulated 4.78 fold, P=0.0012), which is an important gene for the efficiency of CD8 T cell mediated cytotoxicity. Furthermore, downregulation of <italic>Nkg7</italic> in the cytotoxic CD8 T cell subset from Immune-Educated mice may represent a memory phenotype rather than an effector phenotype (<xref ref-type="bibr" rid="B57">57</xref>).</p>
<p>Additionally, the DEGs from the CD4<sup>+</sup> and CD8<sup>+</sup> subsets were queried for overlapping genes. As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>, there was one gene in common between DEGs from quiescent na&#xef;ve CD4 and memory CD4 T cells and two genes in common between DEGs from primed na&#xef;ve CD4 and memory CD4 T cells. Notably, <italic>Nfkbia</italic> was differentially expressed in both primed na&#xef;ve CD4 and memory CD4 T cells which underscores its role in CD4 T cell proliferation and survival (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4H</bold>
</xref>, there was one gene in common between all CD8 subsets, two genes in common between na&#xef;ve and activated CD8 T cells, and one gene in common between na&#xef;ve CD8 and cytotoxic CD8 T cells. The gene in common between all CD8 subsets was <italic>Nfkbia</italic>, which is also essential to CD8 T cell proliferation (<xref ref-type="bibr" rid="B35">35</xref>). Additionally, <italic>Cd48</italic> was upregulated in na&#xef;ve CD8 and activated CD8 T cells suggesting enhanced priming of and cytotoxic capacity for CD8 T cells in mice after Immune Education (<xref ref-type="bibr" rid="B39">39</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Analysis of the genomic changes in CLP mice versus control mice revealed a disorganized T cell immune response to CLP</title>
<p>A list of all significant KEGG pathways in CLP mice relative to Control mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>. A list of all significant DEGs in CLP mice relative to Control mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;5</bold>
</xref>.</p>
<p>Quiescent na&#xef;ve CD4 T cells in CLP mice had 85 significant KEGG pathways with 1 upregulated and 84 downregulated when compared to those in Controls. Among the gene sets affected by CLP was the IL17 signaling pathway (NES -1.75), which is significant because IL17 is a key cytokine for the host innate immune response to mucosal fungal and bacterial infections (<xref ref-type="bibr" rid="B58">58</xref>). Following CLP, the MAPK signaling KEGG pathway (NES -1.76) was also downregulated, and this is notable because MAPK signaling has been implicated in TCR mediated na&#xef;ve CD4 T cell clonal expansion (<xref ref-type="bibr" rid="B59">59</xref>). Hurdle analysis of quiescent na&#xef;ve CD4 T cells identified 131 DEGs; following CLP, expression in 47 was upregulated while expression in 84 was downregulated. Among the genes whose expression were affected by CLP was <italic>Dtx1</italic> (upregulated 4.48 fold, P&lt;0.0001), which is notable because it favors Th17 differentiation following IL6 and TGF&#x3b2; treatment <italic>in vitro</italic> (<xref ref-type="bibr" rid="B60">60</xref>). Another gene whose expression was affected by CLP was <italic>Socs3</italic> (upregulated 4.48 fold, P&lt;0.0001), whose encoded protein has been shown to promote Th17 cell differentiation, reduce IL2 production, and possibly prevent further CD4 T cell proliferation (<xref ref-type="bibr" rid="B61">61</xref>).</p>
<p>GSEA of primed na&#xef;ve CD4 T cells revealed 57 significant KEGG pathways, all downregulated, in CLP mice relative to Controls. Hurdle analysis of primed na&#xef;ve CD4 T cells identified 97 DEGs; following CLP, expression in 30 was upregulated while expression in 67 was downregulated. Among the genes whose expression were affected by CLP were <italic>Dtx1</italic> (upregulated 3.31 fold, P=0.0008) and <italic>Socs3</italic> (upregulated 6.45 fold, P&lt;0.0001), similar to changes seen in the quiescent na&#xef;ve CD4 T cell subset. Additionally, following CLP there was upregulation of <italic>Il7r</italic> (upregulated 4.55 fold, P=0.0001) without corresponding upregulation in downstream members of the <italic>Bcl2</italic> family indicating a lack of downstream IL7 signaling in the primed na&#xef;ve CD4 T cells. Rather, there was downregulation of the <italic>Bcl2</italic> family member <italic>Bcl11b</italic> (downregulated 3.04 fold, P=0.0077) following CLP. Bcl11b is a T-lineage commitment factor essential to thymocyte development and the positive selection of both CD4 and CD8 single positive thymocytes (<xref ref-type="bibr" rid="B62">62</xref>). Moreover, in CD4 T cells Bcl11b is crucial for the induction of <italic>Foxp3</italic> expression in response to TGF-&#x3b2; signaling during peripheral T<sub>reg</sub> proliferation (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). Bcl11b also promotes CD4 T cell differentiation into Th17 cells by repressing <italic>Gata3</italic> expression to restrict Th2 lineage proliferation (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Overall, it was difficult to assess the DEGs between na&#xef;ve CD4 T cells from CLP and Control mice, possibly due to a disorganized T cell immune response characterized by predominantly na&#xef;ve T cell populations.</p>
<p>In the na&#xef;ve CD8 T cell subset, GSEA revealed 169 significant KEGG pathways with 9 upregulated and 160 downregulated in CLP mice compared to Controls. Among the affected gene sets was the PD-L1 expression and PD-1 checkpoint pathway in cancer KEGG pathway (NES -2.06), which is significant because it has been suggested that PD-L1 is a negative regulator of effector CD8 T cell proliferation and response to pathogens <italic>in vivo</italic> (<xref ref-type="bibr" rid="B65">65</xref>). However, concomitant downregulation of the TCR signaling pathway (NES -2.04) following CLP suggests a disorganized T cell immune response in the CLP mice. Hurdle analysis of na&#xef;ve CD8 T cells identified 207 DEGs; following CLP, expression in 29 was upregulated while expression in 178 was downregulated. Among the genes whose expression were affected by CLP was <italic>Ly6a</italic> (<italic>Sca1</italic>; upregulated 10.17 fold, P&lt;0.0001), whose encoded protein is a well-established marker of murine hematopoietic stem cells known to be upregulated on na&#xef;ve CD8 T cells (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>). Ly6a has been shown to be highly expressed during viral-mediated memory CD8 T cell development (<xref ref-type="bibr" rid="B68">68</xref>); however, in a murine knockout model, it was demonstrated that <italic>Ly6a</italic> is not required for the development of competent memory CD8 T cells (<xref ref-type="bibr" rid="B66">66</xref>). Other previously discussed genes that were upregulated in the na&#xef;ve CD8 T cells following CLP include <italic>Dtx1</italic> (upregulated 3.02 fold, P&lt;0.0001), <italic>Runx3</italic> (upregulated 2.66 fold, P&lt;0.0001), <italic>Cd7</italic> (upregulated 2.57 fold, P&lt;0.0001), and <italic>Socs3</italic> (upregulated 2.15 fold, P=0.0002). Among the genes downregulated following CLP in the na&#xef;ve CD8 subset was <italic>Lgals1</italic> (downregulated 2.92 fold, P&lt;0.0001), whose encoded protein galectin-1 is secreted by CD8 T cells to antagonize persistent TCR agonism and tune the CD8 immune response (<xref ref-type="bibr" rid="B69">69</xref>). Downregulation of <italic>Lgals1</italic> suggests susceptibility to a dysregulated CD8 T cell response following CLP. Additionally, in na&#xef;ve CD8 T cells the expression of <italic>Cd28</italic> (downregulated 3.52 fold, P&lt;0.0001) was affected post-CLP, and this is important because <italic>Cd28</italic> is essential to CD8 survival following an acute immune response (<xref ref-type="bibr" rid="B70">70</xref>). Other previously discussed genes that were downregulated in the na&#xef;ve CD8 T cells following CLP include <italic>Nfkbia</italic> (downregulated 3.89 fold, P&lt;0.0001) and <italic>Bcl11b</italic> (downregulated 2.14 fold, P=0.0084).</p>
<p>For activated CD8 T cells there were 97 significant KEGG pathways with 2 upregulated and 95 downregulated in CLP mice when compared to Control mice. Hurdle analysis of activated CD8 T cells identified 125 significant DEGs; following CLP, expression in 46 was upregulated while expression in 79 was downregulated. Among the genes whose expression were affected by CLP was <italic>Il7r</italic> (upregulated 2.55 fold, P &lt;0.001); however, there was no upregulation of downstream <italic>Bcl2</italic> family members suggesting a lack of IL7 signaling in this T cell subset. In fact, there was downregulation of the Bcl-2 family member <italic>Mcl1</italic> (downregulated 2.46 fold, P &lt;0.001) following CLP. Mcl-1 has been shown to antagonize Bim, a pro-apoptotic member of the Bcl-2 protein family, to prevent effector CD8 T cell contraction following acute antigen-driven proliferation and promote activated CD8 T cell proliferation into memory CD8 T cells (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>). Additionally, there was downregulation of <italic>Xcl1</italic> (downregulated 3.96 fold, P=0.0007) following CLP. Xcl-1 (lymphotactin) is released by activated CD8 T cells and binds to Xcr-1 to recruit cross-presenting dendritic cells that enhance cytotoxic CD8 T cell function and promote antigen-specific memory CD8 T cell proliferation (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). These results suggest impaired effector and memory CD8 T cell expansion in CLP mice compared to Control mice.</p>
<p>The memory CD4 T cells from CLP when compared to Control had 76 significant KEGG pathways with 1 upregulated and 75 downregulated. Hurdle analysis of memory CD4 T cells identified 123 DEGs; following CLP, expression in 45 was upregulated while expression in 78 was downregulated. Notably, following CLP there was upregulation in the expression of <italic>Il7r</italic> (upregulated 5.57 fold, P&lt;0.0001) and <italic>Bcl2</italic> (upregulated 2.79 fold, P=0.0019). This points towards development of a memory CD4 T cell pool following exposure to CLP.</p>
<p>In the cytotoxic CD8 T cell subset there were 24 significant KEGG pathways, all upregulated, in the CLP mice when compared to Controls. Hurdle analysis of cytotoxic CD8 T cells identified 56 DEGs; following CLP expression in 25 was upregulated while expression in 31 was downregulated. Among the upregulated genes in cytotoxic CD8 T cells following CLP was <italic>Ly6a</italic> (upregulated 11.35 fold, P&lt;0.0001). Among the downregulated genes in cytotoxic CD8 T cells following CLP were <italic>Lgals1</italic> (downregulated 6.33 fold, P=0.0058), <italic>Bcl10</italic> (downregulated 3.87 fold, P=0.0019), and <italic>Nfkbia</italic> (downregulated 2.50 fold, P=0.0093).</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Transcriptomic changes in immune-educated CLP mice versus immune-educated mice demonstrated distinct CD4 and CD8 T cell responses to CLP</title>
<p>A list of all significant KEGG pathways in Immune-Educated CLP mice relative to Immune-Educated mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;6</bold>
</xref>. A list of all significant DEGs in Immune-Educated CLP mice relative to Immune-Educated mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;7</bold>
</xref>.</p>
<p>Within the quiescent na&#xef;ve CD4 T cell subset, GSEA revealed 79 upregulated pathways in Immune-Educated CLP mice when compared to Immune-Educated mice. Affected KEGG pathways included antigen processing and presentation (NES 1.60), IL-17 signaling pathway (NES 1.57), and TCR signaling (NES 1.37) suggestive of a coordinated T cell response to CLP in quiescent na&#xef;ve CD4 T cells following Immune Education. Hurdle analysis of quiescent na&#xef;ve CD4 T cells identified 48 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 24 was upregulated while expression in 24 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). Among the upregulated genes was <italic>Socs3</italic> (upregulated 5.56 fold, P&lt;0.0001), which suggests a Th17-skewed na&#xef;ve CD4 T cell response to CLP (<xref ref-type="bibr" rid="B75">75</xref>). There was also upregulation of <italic>Il7r</italic> (upregulated 2.13 fold, P&lt;0.0001), but no upregulation in downstream members of the <italic>Bcl2</italic> family to indicate IL7-mediated signaling in the quiescent na&#xef;ve CD4 T cells. Another upregulated gene in quiescent na&#xef;ve CD4 T cells from Immune-Educated CLP mice was <italic>Dtx1</italic> (upregulated 3.70 fold, P&lt;0.0001), which is a downstream transcription factor induced by NFAT signaling that promotes T cell anergy (<xref ref-type="bibr" rid="B76">76</xref>). Together these results suggest an immune state favoring na&#xef;ve CD4 T cell contraction following antigen-mediated TCR signaling.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Hurdle analysis was performed within each T cell subset to see if there were differentially expressed genes in Immune-Educated CLP mice relative to Immune-Educated mice. Volcano plots were used to show the adjusted P values and log2 fold change values from these analyses. Red dots indicate upregulated genes, blue dots indicate downregulated genes, and gray dots represent insignificant or inconclusively different genes in Immune-Educated CLP mice relative to Immune-Educated mice. The top 5 upregulated and top 5 downregulated genes are labeled on the volcano plots. Results for <bold>(A)</bold> quiescent na&#xef;ve CD4, <bold>(B)</bold> primed na&#xef;ve CD4, <bold>(C)</bold> na&#xef;ve CD8, <bold>(D)</bold> activated CD8, <bold>(E)</bold> memory CD4, and <bold>(F)</bold> cytotoxic CD8 T cells are shown. The full list of DEGs can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;7</bold>
</xref>. Overlapping DEGs in the <bold>(G)</bold> CD4<sup>+</sup> subsets and <bold>(H)</bold> CD8<sup>+</sup> subsets were identified and depicted on Venn diagrams.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g005.tif"/>
</fig>
<p>For primed na&#xef;ve CD4 T cells, GSEA identified 64 KEGG pathways of significance with 1 upregulated and 63 downregulated from the Immune-Educated CLP mice relative to Immune-Educated mice. Hurdle analysis of primed na&#xef;ve CD4 T cells identified 58 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 19 was upregulated while expression in 39 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Like in the quiescent na&#xef;ve CD4 T cell subset, there was upregulation of <italic>Socs3</italic> (upregulated 4.23 fold, P&lt;0.0001) and <italic>Dtx1</italic> (upregulated 4.11 fold, P&lt;0.0001) in primed na&#xef;ve CD4 T cells from Immune-Educated CLP mice relative to those from Immune-Educated mice. Also, there was once again upregulation of <italic>Il7r</italic> (upregulated 4.08 fold, P&lt;0.0001) in primed na&#xef;ve CD4 T cells from Immune-Educated CLP mice without change in downstream <italic>Bcl2</italic> family gene expression. These results are again suggestive of conditions favoring na&#xef;ve CD4 T cell contraction following T cell signaling.</p>
<p>GSEA of na&#xef;ve CD8 T cells from Immune-Educated CLP mice versus Immune-Educated mice revealed 96 significant KEGG pathways with 2 upregulated and 94 downregulated. Hurdle analysis of na&#xef;ve CD8 T cells identified 85 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 18 was upregulated while expression in 67 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). Previously discussed genes that were upregulated in the na&#xef;ve CD8 T cells from Immune-Educated CLP mice include <italic>Dtx1</italic> (upregulated 4.62 fold, P&lt;0.0001), <italic>Ly6a</italic> (upregulated 3.10 fold, P&lt;0.0001), <italic>Cd7</italic> (upregulated 2.86 fold, P&lt;0.0001), and <italic>Socs3</italic> (upregulated 2.30 fold, P&lt;0.0001). There was again upregulation of <italic>Il7r</italic> (upregulated 2.12 fold, P=0.0032) without corresponding upregulation in <italic>Bcl2</italic> family members. Among the downregulated genes in na&#xef;ve CD8 T cells from Immune-Educated CLP was <italic>Lgals1</italic> (downregulated 5.00 fold, P&lt;0.0001), whose encoded protein galectin-1 tunes the CD8 immune response as previously discussed (<xref ref-type="bibr" rid="B69">69</xref>). Moreover <italic>Cd5</italic> (downregulated 2.54 fold, P=0.0002) and <italic>Cd28</italic> (downregulated 2.39 fold, P&lt;0.0025), genes encoding two previously discussed cell surface molecules, were downregulated in na&#xef;ve CD8 from Immune-Educated CLP mice when compared to Immune-Educated mice. Together, these findings point towards a dysregulated na&#xef;ve CD8 response with impaired CD8 T cell expansion in response to CLP in mice that underwent Immune Education.</p>
<p>In the activated CD8 T cell subset, 57 significant KEGG pathways were identified on GSEA of Immune-Educated CLP versus Immune-Educated with 7 upregulated and 50 downregulated. Hurdle analysis of activated CD8 T cells identified 59 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 9 was upregulated while expression in 50 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). Previously discussed genes that were upregulated in activated CD8 T cells from Immune-Educated CLP mice included <italic>Nfkbia</italic> (upregulated 2.93 fold, P=0.0004) and <italic>Ly6a</italic> (upregulated 3.04 fold, P=0.0013). Among the downregulated genes in activated CD8 T cells from Immune-Educated CLP mice was <italic>Il18r1</italic> (downregulated 3.21 fold, P=0.0011), which is upregulated in effector CD8 T cells during acute viral infection and downregulated in exhausted CD8 T cells during chronic infection (<xref ref-type="bibr" rid="B77">77</xref>). Other previously discussed genes that were downregulated in the activated CD8 T cells from Immune-Educated CLP mice include <italic>Lgals1</italic> (downregulated 8.01 fold, P&lt;0.0001) and <italic>Cd28</italic> (downregulated 3.26 fold, P=0.0007). These results are suggestive of an acute CD8 response to CLP which may be dysregulated in Immune-Educated mice.</p>
<p>In the memory CD4 T cell subset there were 91 downregulated KEGG pathways in Immune-Educated CLP when compared Immune-Educated. Hurdle analysis of memory CD4 T cells identified 104 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 28 was upregulated while expression in 76 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>). One of the upregulated genes was <italic>Izumo1r</italic> (upregulated 5.04 fold, P&lt;0.0001), which is expressed in <italic>Foxp3</italic>
<sup>+</sup> T<sub>reg</sub> cells and was recently shown to facilitate T<sub>reg</sub> tight contacts with &#x3b3;&#x3b4;T cells to mediate psoriasis-like inflammation in the dermis (<xref ref-type="bibr" rid="B78">78</xref>). There was also upregulation of <italic>Socs3</italic> (upregulated 3.66 fold, P&lt;0.0001), which implies a Th17-skewed environment (<xref ref-type="bibr" rid="B61">61</xref>). Additionally, there was upregulation of <italic>Il7r</italic> (upregulated 2.33 fold, P&lt;0.0001). Previously discussed genes that were downregulated in the memory CD4 T cell subset from Immune-Educated CLP mice include <italic>Lgals1</italic> (downregulated 6.27 fold, P&lt;0.0001) and <italic>Il18r1</italic> (downregulated 3.01 fold, P&lt;0.0001).</p>
<p>Cytotoxic CD8 T cells from Immune-Educated CLP mice had 3 upregulated KEGG pathways relative to Immune-Educated mice. Hurdle analysis of cytotoxic CD8 T cells identified 19 DEGs; following Immune Education and CLP versus Immune Education alone, expression in 12 was upregulated while expression in 7 was downregulated (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>). Among the upregulated genes was <italic>Pdcd4</italic> (upregulated 2.76 fold, P=0.0014), whose encoded protein has been implicated in T cell exhaustion and apoptosis (<xref ref-type="bibr" rid="B79">79</xref>).</p>
<p>Additionally, the DEGs from the CD4<sup>+</sup> and CD8<sup>+</sup> subsets were searched for overlapping genes. As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>, there were eleven genes in common between all CD4, eleven genes in common between quiescent na&#xef;ve CD4 and primed na&#xef;ve CD4, five genes in common between quiescent na&#xef;ve CD4 and memory CD4, and seven genes in common between primed na&#xef;ve CD4 and memory CD4 T cells. Notably <italic>Il7r</italic>, which plays a central role in T cell proliferation and survival was differentially expressed in all CD4 subsets (<xref ref-type="bibr" rid="B13">13</xref>). As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5H</bold>
</xref>, there were sixteen genes in common between na&#xef;ve CD8 and activated CD8, one gene in common between na&#xef;ve CD8 and memory CD8, and two genes in common between na&#xef;ve and activated CD8 T cells. Among the genes differentially expressed in both na&#xef;ve CD8 and activated CD8 T cells was <italic>CD28</italic> (downregulated in both subsets), which plays a role in effector CD8 T cell survival following activation (<xref ref-type="bibr" rid="B70">70</xref>), and <italic>Lgals1</italic> (downregulated in both subsets) which encodes galectin-1, a protein released by CD8 T cells to antagonize persistent TCR activation (<xref ref-type="bibr" rid="B69">69</xref>). No gene was differentially expressed in all CD8 subsets.</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Immune education prior to CLP enhanced TCR signaling with transcriptomic signatures suggesting improved T cell survival and function</title>
<p>A list of all significant KEGG pathways in Immune-Educated CLP mice relative to CLP mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;8</bold>
</xref>. A list of all significant DEGs in Immune-Educated CLP mice relative to CLP mice across the T cell subsets can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;9</bold>
</xref>.</p>
<p>In the quiescent na&#xef;ve CD4 T cell subset, GSEA identified 79 KEGG pathways of significance with all upregulated in Immune-Educated CLP mice when compared to CLP mice. Network analysis using GSEA results (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>) demonstrated an edge&#x2014;a connection between gene set nodes based on the degree of overlapping genes&#x2014;connecting the TCR (NES 1.37) and B cell receptor (NES 1.39) signaling pathways. This indicates overlap between these two signaling pathways. Among the genes within the edge were <italic>Nfatc1</italic> and <italic>Nfatc2</italic>, which encode transcription factors necessary for both T cell and B cell survival (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>). Hurdle analysis of quiescent na&#xef;ve CD4 T cells identified 31 DEGs; following Immune Education and CLP versus CLP alone, expression in 24 was upregulated while expression in 7 was downregulated. Among the affected genes in the Immune-Educated CLP mice was <italic>Bsg</italic> (upregulated 2.29 fold, P &lt;0.001), whose encoded protein basigin/CD147 has been shown to play a role in T cell activation and T<sub>reg</sub> differentiation, and because of this it has been studied as a potential therapeutic target for inflammatory diseases (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). There was also upregulation of <italic>Cdc42</italic> (upregulated 2.25 fold, P &lt;0.001), whose encoded protein (a Rho family GTPase) has been shown to play an essential role in actin polymerization for TCR clustering, Th1 differentiation, and memory cell survival in na&#xef;ve CD4 T cells (<xref ref-type="bibr" rid="B84">84</xref>). Another gene whose expression was upregulated following Immune-Educated CLP was <italic>Rac1</italic> (upregulated 2.22 fold, P &lt;0.001), which encodes another Rho family GTPase that plays a critical role in CD4 single-positive T cell differentiation by preventing TCR-induced apoptosis via <italic>Bcl2</italic> upregulation (<xref ref-type="bibr" rid="B85">85</xref>). Among the downregulated genes was <italic>Zbp1</italic> (downregulated 3.44 fold, P &lt;0.001), whose encoded protein is an important immune sensor critical to initiation of the innate immune response to pathogens. However, excessive <italic>Zbp1</italic> mediated PANoptosis has been shown to have detrimental host effects, thus <italic>Zbp1</italic> signaling may play a critical role in immune homeostasis (<xref ref-type="bibr" rid="B86">86</xref>). Together these results suggest enhanced na&#xef;ve CD4 TCR signaling in response to CLP following Immune Education.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Network analysis, using Cytoscape, was performed using the GSEA results from the Immune- Educated CLP versus CLP experimental group comparison. Representative plots were created for the <bold>(A)</bold> quiescent na&#xef;ve CD4 T cell and <bold>(B)</bold> na&#xef;ve CD8 T cell subsets. Each node represents a KEGG gene set, with node sizes representative of the gene set size and node color representative of the degree of normalized enrichment. Nodes are connected by edges, which are determined by the degree of overlapping genes between nodes. Gene sets with the 5 highest NES within each T cell subset and others of interest were labeled.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g006.tif"/>
</fig>
<p>In the primed na&#xef;ve CD4 T cell subset there were 60 significant KEGG pathways that were all upregulated with Immune-Educated CLP relative to CLP. Hurdle analysis of primed na&#xef;ve CD4 T cells identified 24 DEGs; following Immune Education and CLP versus CLP alone, expression in 22 was upregulated while expression in 2 was downregulated. Two of the upregulated genes were <italic>Lck</italic> (upregulated 2.39 fold, P &lt;0.001) and <italic>Cd2</italic> (upregulated 2.26 fold, P&lt;0.001). Lck is a member of the Src family of protein tyrosine kinases, and it is involved in TCR phosphorylation which regulates initiation of TCR signaling and T cell development (<xref ref-type="bibr" rid="B87">87</xref>). CD2 has been shown to interact with Lck as a co-stimulatory molecule in T cell activation (<xref ref-type="bibr" rid="B88">88</xref>). Additionally, there was upregulation of <italic>Cdc42</italic> (upregulated 2.14 fold, P=0.0012), which may again indicate enhanced na&#xef;ve CD4 TCR signaling in Immune-Educated CLP mice when compared to CLP mice.</p>
<p>For na&#xef;ve CD8 T cells from Immune-Educated CLP mice, GSEA revealed 128 upregulated pathways relative to those from CLP mice. Network analysis using GSEA results (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>) demonstrated an edge connecting the TCR signaling pathway (NES 1.62) and PD-L1 expression and PD-1 checkpoint pathway in cancer (NES 1.43) &#x2013; these processes are likely connected given the acute upregulation of PD-1 in response to TCR activation (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>). Hurdle analysis of na&#xef;ve CD8 T cells identified 77 DEGs; following Immune Education and CLP versus CLP alone, expression in 68 was upregulated while expression in 9 was downregulated. One of the upregulated genes was <italic>Nkg7</italic> (upregulated 2.66 fold, P&lt;0.0001), whose encoded protein has been shown to improve the efficiency of CD8 T cell synapse formation to enhance cytotoxic effects and limit inflammation (<xref ref-type="bibr" rid="B57">57</xref>). Other previously discussed genes that were upregulated with Immune-Educated CLP relative to CLP include <italic>Cd7</italic> (upregulated 2.69 fold, P=0.0019), <italic>CD28</italic> (upregulated 2.51 fold, P=0.0034), and <italic>Mcl1</italic> (upregulated 2.34 fold, P=0.0088). These findings indicate enhanced na&#xef;ve CD8 T cell survival for mice exposed to CLP after Immune Education. Among the downregulated genes was <italic>Pdcd6</italic> (<italic>Alg2</italic>; downregulated 2.44 fold, P=0.0043), whose encoded protein plays a role in TCR mediated programmed cell death by affecting the stability of Mcl1 following T cell activation to promote apoptosis (<xref ref-type="bibr" rid="B91">91</xref>). These results suggest enhanced survival of na&#xef;ve CD8 T cells post-CLP following Immune Education versus without.</p>
<p>GSEA of activated CD8 T cells revealed 10 upregulated KEGG pathways in Immune-Educated CLP mice versus CLP mice. Hurdle analysis of activated CD8 T cells identified 37 DEGs; following Immune Education and CLP versus CLP alone, expression in 17 was upregulated while expression in 20 was downregulated. Among the upregulated genes was <italic>Klrc1</italic> (<italic>Nkg2a</italic>; upregulated 2.89 fold, P=0.0041). <italic>Klrc1</italic> has been shown to be inversely correlated with CD8 T<sub>reg</sub> function in anti-CD3 mAb stimulated human CD8 T cells (<xref ref-type="bibr" rid="B92">92</xref>). <italic>Nfkbia</italic> expression was again affected (upregulated 3.15 fold, P=0.0027) indicating enhanced CD8 T cell immune function (<xref ref-type="bibr" rid="B93">93</xref>). Among the downregulated genes in activated CD8 T cells following Immune-Educated CLP versus CLP was <italic>Slamf6</italic> (downregulated 2.35 fold, P=0.0006), whose encoded protein is a CD2 family member that has been implicated in CD8 exhaustion. It has been shown that anti-SLAMF6 could correct CD8 dysfunction in leukemias and lymphomas (<xref ref-type="bibr" rid="B94">94</xref>).</p>
<p>Within the memory CD4 T cell subset, GSEA revealed 48 upregulated pathways in Immune-Educated CLP compared to CLP. Hurdle analysis of memory CD4 T cells identified 46 DEGs; following Immune Education and CLP versus CLP alone, expression in 28 was upregulated while expression in 18 was downregulated. One of the upregulated genes was <italic>Txk</italic> (upregulated 2.35 fold, P=0.0040), which encodes a member of the Tec family of non-receptor tyrosine kinases. It has been suggested that <italic>Txk</italic> may have a role in potentiating Th2 function in memory T cells (<xref ref-type="bibr" rid="B95">95</xref>). One of the downregulated genes was <italic>Il7r</italic> (downregulated 2.78 fold, P=0.0037).</p>
<p>In cytotoxic CD8 T cells from Immune-Educated CLP mice, GSEA revealed 5 significant pathways with 1 upregulated and 4 downregulated relative to those from CLP mice. Hurdle analysis of cytotoxic CD8 T cells identified 12 DEGs; following Immune Education and CLP versus CLP alone, expression in 10 was upregulated while expression in 2 was downregulated.</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Immune Education upregulated T cell IL7R expression in mice exposed to CLP</title>
<p>Several of the subpopulations in the Immune-Educated CLP mice in our scRNA-seq analysis demonstrated upregulation of the IL7R signaling pathway. <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref> shows a heat map of genes involved in the IL7R (CD127) pathway across all T cells by experimental group. There was upregulation of <italic>Il7r</italic> for CLP and Immune-Educated CLP mice, but <italic>Il2rg</italic>, <italic>Bcl2l1</italic>, and <italic>Bax</italic> were only upregulated in the Immune-Educated mice. Additionally, <italic>Bcl2</italic> was upregulated with Immune-Educated and Immune-Educated CLP, but not CLP. <italic>Mcl1</italic> was also upregulated in Immune-Educated CLP. The Bcl-2 family of proteins are located on the outer mitochondrial membrane and control mitophagy by regulating voltage-dependent anion channels to influence mitochondrial Ca<sup>2+</sup> signaling (<xref ref-type="bibr" rid="B96">96</xref>). Bax and Bak are proapoptotic members of the Bcl-2 family essential to mitochondrial-dependent apoptotic pathways in multiple cell types, including T cells (<xref ref-type="bibr" rid="B97">97</xref>). We performed flow cytometry to validate these finding in our mouse model and found that Immune Education had a statistically significant effect on IL7R (CD127) expression in mice subjected to CLP for CD4 (P<sub>Int</sub>=0.0110; <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>) and CD8 T cells (P<sub>Int</sub>=0.0109; <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>
<bold>(A)</bold> Using the scRNA-seq data, a heat map of genes involved in the IL7R pathway across all T cells by experimental group was created for visualization. Dot plots were created to display the percent of IL7R/CR127<sup>+</sup> T cells on flow cytometric analysis for <bold>(B)</bold> CD4 T cells and <bold>(C)</bold> CD8 T cells across the experimental groups (Con=Control, Edu=Immune-Educated, CLP=CLP, and Edu+CLP=Immune-Educated CLP) to corroborate scRNA-seq findings of increased IL7R/CD127 expression following CLP and Immune-Educated CLP. It was shown that Immune Education increased the proportion of CD127<sup>+</sup> CD4 and CD8 T cells when exposed to CLP.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1366955-g007.tif"/>
</fig>
<p>These findings are significant given the role of IL7 in T cell survival. A prior study has demonstrated that recombinant human IL7 (rhIL7) treatment 24-48 hours after CLP exposure blocks CD4 and CD8 T cell apoptosis in mice following CLP exposure by increasing Bcl-2 (<xref ref-type="bibr" rid="B13">13</xref>). This has led to trials investigating the effect of IL7 in human sepsis (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). The IL7R pathway is one example of how findings from this study can be applied to other investigations.</p>
</sec>
</sec>
<sec id="s4" sec-type="conclusions">
<label>4</label>
<title>Conclusion</title>
<p>Following antigenic stimulation via the TCR there is expansion and differentiation of activated T cells. After clearance of a pathogen, a balanced immune response will eliminate excess effector T cells while generating a memory T cell pool (<xref ref-type="bibr" rid="B98">98</xref>). One of the major limitations in translating work from murine sepsis models to humans has been the lack of memory T cell compartments in mice that are bred in sterile facilities (<xref ref-type="bibr" rid="B6">6</xref>). There are several highly salient points that arise from the current work. Most importantly, we identify that T cell responses following CLP are not homogenous. Our work identifies several subsets of na&#xef;ve and memory CD4 and CD8 T cells that likely have variable responses and functionally contribute differing factors to the overall response to CLP. The same is likely true of the human T cell response to sepsis. To date though, very little has been done examining differential T cell subset responses in human sepsis. It is theorized that some T cells in sepsis are directed against the sepsis-inciting pathogen while others are inappropriately activated, and still others are undergoing apoptosis, T<sub>reg</sub> cell differentiation, or other types of elimination. The variation in T cell subset responses to sepsis and severe inflammation deserves further examination in future studies.</p>
<p>The role of T cell memory in modulation of the T cell immune response also warrants further discussion. Immune Education in our model promoted widespread changes in many pathways following CLP, indicating that T cell memory is a major factor in modulation of the immune response to major infection and likely to human sepsis. Several seminal papers have argued that the immune response in mice, using transcriptomic methods, fail to emulate the human immune response (<xref ref-type="bibr" rid="B99">99</xref>). Similar papers have pointed out, using the same data, that several aspects of the immune response emulate human responses, but the transcriptomic signatures that do not concur have led to major consternation in sepsis research (<xref ref-type="bibr" rid="B100">100</xref>). The manuscript by Takao et&#xa0;al. demonstrated that ZAP70 signaling, which is downstream of TCR activation was highly concurrent. This indicates similar TCR signaling between human conditions and murine models; without prior induction of T cell memory, the responses to that TCR signaling in the mouse models may have been drastically different. Our work indicates that T cell memory may have been a driving factor in the malalignment between the murine and human transcriptomic responses discussed in these research studies and this deserves further examination.</p>
<p>There are important limitations to our work and to transcriptomic studies. Single-cell RNA sequencing data lacks the ability to detect functional outcomes &#x2013; without concurrent protein data, it is difficult to ascertain whether these pathways are leading to cytokine production, changes in cytolytic responses, or alterations in signaling pathways. Further immunologic functional assays are required to substantiate these findings. Much has also been said as to the use of the CLP model. Herein, we used a relatively severe model &#x2013; this may have biased our results, though it did allow us to demonstrate several important principles that have broad relevance beyond the model itself &#x2013; and observed responses at a single, early post-CLP time point. The Immune Education method of T cell memory induction is artificial and induces a relatively uniform memory T cell population that may not emulate natural exposures, though in comparison to other T cell &#x201c;memory induction&#x201d; methods it does generate broad T cell clonality that is likely closer to the T cell memory in humans. The artificial nature of this induction is balanced by the extreme difficulty of parsing out changes specific to T cell memory and other changes in the innate immune system or the rest of the body caused by natural exposures. Further, work using naturalized mice has many biosafety issues that further limit their use in research studies, making Immune Education a highly accessible and useful model to examine the role of memory T cells in disease models.</p>
<p>Finally, we found several important pathways that may be highly relevant in altering the immune response to CLP. The Th17 response and other T cell effector pathways were upregulated in many T cell subsets in Immune-Educated mice, indicating that T cell memory could alter several other aspects of the CLP response, as we have previously demonstrated (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B10">10</xref>). We also demonstrate that Immune Education increased expression of surface IL7R and genes downstream of the IL7R signaling pathway upon CLP exposure.</p>
<p>Our use of scRNA-seq uniquely captured the diversity of the full T cell repertoire in immunity. &#x201c;Bulk&#x201d; RNA sequencing, which has been the conventional approach to animal and clinical studies assessing T cell response in sepsis, would not allow for the nuanced analysis of T cell subsets performed in this study. However, the scRNA-seq findings presented in this paper are observational in nature and limited because they do not offer mechanistic insights. Future studies will entail utilizing Immune Education prior to CLP to further query mechanisms underlying T cell dysfunction in sepsis.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) repository, accession number PRJNA1079500. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Institutional Animal Care and Use Committee (IACUC #2017-039). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>SH: Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. MA: Investigation, Methodology, Writing &#x2013; review &amp; editing. CD: Conceptualization, Funding acquisition, Methodology, Supervision, Writing &#x2013; review &amp; editing. MT: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. CD received funding from the NIH NIGMS R01GM121102. MT received funding from the NIH NIGMS K08GM132794 and from the Thrasher Research Fund Early Career Award 14734.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Annette Lee and Houman Khalili at the Feinstein Institute for their assistance in performing the sequencing experiment.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1366955/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1366955/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tiff" id="SF1" mimetype="image/tiff"/>
<supplementary-material xlink:href="Table_1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Table_2.xls" id="SM2" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_3.xls" id="SM3" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_4.xls" id="SM4" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_5.xls" id="SM5" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_6.xls" id="SM6" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_7.xls" id="SM7" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_8.xls" id="SM8" mimetype="application/vnd.ms-excel"/>
<supplementary-material xlink:href="Table_9.xls" id="SM9" mimetype="application/vnd.ms-excel"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Seymour</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Shankar-Hari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Annane</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source>Jama</source>. (<year>2016</year>) <volume>315</volume>(<issue>8</issue>):<page-range>801&#x2013;10</page-range>. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>. <source>Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions</source>.. <publisher-loc>Geneva, Switzerland</publisher-loc> (<year>2020</year>).</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleischmann</surname> <given-names>C</given-names>
</name>
<name>
<surname>Scherag</surname> <given-names>A</given-names>
</name>
<name>
<surname>Adhikari</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Hartog</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Tsaganos</surname> <given-names>T</given-names>
</name>
<name>
<surname>Schlattmann</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2016</year>) <volume>193</volume>(<issue>3</issue>):<page-range>259&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1164/rccm.201504-0781OC</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Hamad</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pande</surname> <given-names>A</given-names>
</name>
<name>
<surname>Varon</surname> <given-names>J</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals</article-title>. <source>JAMA Network Open</source>. (<year>2019</year>) <volume>2</volume>(<issue>2</issue>):<fpage>e187571</fpage>&#x2013;<lpage>e187571</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.7571</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osuchowski</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Ayala</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bahrami</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Boros</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cavaillon</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): An international expert consensus initiative for improvement of animal modeling in sepsis</article-title>. <source>Shock</source>. (<year>2018</year>) <volume>50</volume>(<issue>4</issue>):<page-range>377&#x2013;80</page-range>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000001212</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beura</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Hamilton</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schenkel</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Odumade</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Casey</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Normalizing the environment recapitulates adult human immune traits in laboratory mice</article-title>. <source>Nature</source>. (<year>2016</year>) <volume>532</volume>(<issue>7600</issue>):<page-range>512&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature17655</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abolins</surname> <given-names>S</given-names>
</name>
<name>
<surname>King</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Lazarou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Weldon</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>L</given-names>
</name>
<name>
<surname>Drescher</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The comparative immunology of wild and laboratory mice, mus musculus domesticus</article-title>. <source>Nat Commun</source>. (<year>2017</year>) <volume>8</volume>:<fpage>14811</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms14811</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Abraham</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>CD4 and CD8 T cell memory interactions alter innate immunity and organ injury in the CLP sepsis model</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>563402</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.563402</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Induction of diverse T cell memory through antibody-mediated activation in mice</article-title>. <source>Eur J Immunol</source>. (<year>2020</year>) <volume>50</volume>(<issue>11</issue>):<page-range>1838&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.202048570</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Nedeljkovic-Kurepa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Reddy</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Abraham</surname> <given-names>MN</given-names>
</name>
<etal/>
</person-group>. <article-title>CD4 t follicular helper cells prevent depletion of follicular b cells in response to cecal ligation and puncture</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>1946</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01946</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname> <given-names>K</given-names>
</name>
<name>
<surname>Al-Haidari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kazi</surname> <given-names>JU</given-names>
</name>
</person-group>. <article-title>T cell receptor (TCR) signaling in health and disease</article-title>. <source>Signal Transduction Targeted Ther</source>. (<year>2021</year>) <volume>6</volume>(<issue>1</issue>):<fpage>412</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-021-00823-w</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patke</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Ahmadzadeh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bingaman</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Farber</surname> <given-names>DL</given-names>
</name>
</person-group>. <article-title>Anti-CD3 priming generates heterogeneous antigen-specific memory CD4 T cells</article-title>. <source>Clin Immunol</source>. (<year>2005</year>) <volume>117</volume>(<issue>2</issue>):<page-range>125&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.clim.2005.07.012</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unsinger</surname> <given-names>J</given-names>
</name>
<name>
<surname>McGlynn</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kasten</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Hoekzema</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>E</given-names>
</name>
<name>
<surname>Muenzer</surname> <given-names>JT</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>(<issue>7</issue>):<page-range>3768&#x2013;79</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0903151</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francois</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jeannet</surname> <given-names>R</given-names>
</name>
<name>
<surname>Daix</surname> <given-names>T</given-names>
</name>
<name>
<surname>Walton</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Shotwell</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Unsinger</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial</article-title>. <source>JCI Insight</source>. (<year>2018</year>) <volume>3</volume>(<issue>5</issue>):<elocation-id>e98960</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/jci.insight.98960</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Simone</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rossetti</surname> <given-names>G</given-names>
</name>
<name>
<surname>Pagani</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Single cell T cell receptor sequencing: Techniques and future challenges</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01638</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jameson</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Masopust</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Understanding subset diversity in T cell memory</article-title>. <source>Immunity</source>. (<year>2018</year>) <volume>48</volume>(<issue>2</issue>):<page-range>214&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2018.02.010</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Specificity and function of T cell subset identities using single-cell sequencing</article-title>. <source>Clin Trans Discovery.</source>. (<year>2023</year>) <volume>3</volume>(<issue>3</issue>):<elocation-id>e199</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/ctd2.199</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diodato</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Kn&#xf6;ferl</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Schwacha</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Bland</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Chaudry</surname> <given-names>IH</given-names>
</name>
</person-group>. <article-title>Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis</article-title>. <source>Cytokine</source>. (<year>2001</year>) <volume>14</volume>(<issue>3</issue>):<page-range>162&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1006/cyto.2001.0861</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vardon-Bounes</surname> <given-names>F</given-names>
</name>
<name>
<surname>Merlet-Dupuy</surname> <given-names>V</given-names>
</name>
<name>
<surname>Conil</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Bul&#xe9;on</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fourcade</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture</article-title>. <source>Intensive Care Med Exp</source>. (<year>2016</year>) <volume>4</volume>(<issue>1</issue>):<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40635-016-0096-z</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abcejo</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Andrejko</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Raj</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Deutschman</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Failed interleukin-6 signal transduction in murine sepsis: attenuation of hepatic glycoprotein 130 phosphorylation</article-title>. <source>Crit Care Med</source>. (<year>2009</year>) <volume>37</volume>(<issue>5</issue>):<page-range>1729&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1097/CCM.0b013e31819dee81</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alverdy</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Keskey</surname> <given-names>R</given-names>
</name>
<name>
<surname>Thewissen</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Can the cecal ligation and puncture model be repurposed to better inform therapy in human sepsis</article-title>? <source>Infect Immun</source>. (<year>2020</year>) <volume>88</volume>(<issue>9</issue>):<page-range>e00942&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00942-19</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Khande</surname> <given-names>H</given-names>
</name>
<name>
<surname>Periasamy</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mokale</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Immunomodulatory effect of doxycycline ameliorates systemic and pulmonary inflammation in a murine polymicrobial sepsis model</article-title>. <source>Inflammation</source>. (<year>2020</year>) <volume>43</volume>(<issue>3</issue>):<page-range>1035&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s10753-020-01188-y</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luecken</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Theis</surname> <given-names>FJ</given-names>
</name>
</person-group>. <article-title>Current best practices in single-cell RNA-seq analysis: a tutorial</article-title>. <source>Mol Syst Biol</source>. (<year>2019</year>) <volume>15</volume>(<issue>6</issue>):<elocation-id>e8746</elocation-id>. doi: <pub-id pub-id-type="doi">10.15252/msb.20188746</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilicic</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Kolodziejczyk</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Bagger</surname> <given-names>FO</given-names>
</name>
<name>
<surname>McCarthy</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Marioni</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Classification of low quality cells from single-cell RNA-seq data</article-title>. <source>Genome Biol</source>. (<year>2016</year>) <volume>17</volume>(<issue>1</issue>):<fpage>29</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-016-0888-1</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Furumichi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kawashima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ishiguro-Watanabe</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>KEGG for taxonomy-based analysis of pathways and genomes</article-title>. <source>Nucleic Acids Res</source>. (<year>2023</year>) <volume>51</volume>(<issue>D1</issue>):<fpage>D587</fpage>&#x2013;<lpage>d592</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkac963</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname> <given-names>P</given-names>
</name>
<name>
<surname>Markiel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ozier</surname> <given-names>O</given-names>
</name>
<name>
<surname>Baliga</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Ramage</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>. (<year>2003</year>) <volume>13</volume>(<issue>11</issue>):<page-range>2498&#x2013;504</page-range>. doi: <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finak</surname> <given-names>G</given-names>
</name>
<name>
<surname>McDavid</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yajima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gersuk</surname> <given-names>V</given-names>
</name>
<name>
<surname>Shalek</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data</article-title>. <source>Genome Biol</source>. (<year>2015</year>) <volume>16</volume>(<issue>1</issue>):<fpage>278</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerman</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Espeland</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Langefeld</surname> <given-names>CD</given-names>
</name>
</person-group>. <article-title>A practical solution to pseudoreplication bias in single-cell studies</article-title>. <source>Nat Commun</source>. (<year>2021</year>) <volume>12</volume>(<issue>1</issue>):<fpage>738</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-21038-1</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaminskiy</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kuznetsova</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kudriaeva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zmievskaya</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bulatov</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Neglected, yet significant role of FOXP1 in t-cell quiescence, differentiation and exhaustion</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>971045</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.971045</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wurbel</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Malissen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Complex regulation of CCR9 at multiple discrete stages of T cell development</article-title>. <source>Eur J Immunol</source>. (<year>2006</year>) <volume>36</volume>(<issue>1</issue>):<fpage>73</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1002/eji.200535203</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorner</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Scheffold</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rolph</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Huser</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Kaufmann</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Radbruch</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2002</year>) <volume>99</volume>(<issue>9</issue>):<page-range>6181&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.092141999</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chopp</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Gopalan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ciucci</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ruchinskas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rae</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lagarde</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>An integrated epigenomic and transcriptomic map of mouse and human &#x3b1;&#x3b2; T cell development</article-title>. <source>Immunity</source>. (<year>2020</year>) <volume>53</volume>(<issue>6</issue>):<fpage>1182</fpage>&#x2013;<lpage>1201.e1188</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2020.10.024</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akashi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kondo</surname> <given-names>M</given-names>
</name>
<name>
<surname>von Freeden-Jeffry</surname> <given-names>U</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>R</given-names>
</name>
<name>
<surname>Weissman</surname> <given-names>IL</given-names>
</name>
</person-group>. <article-title>Bcl-2 rescues t lymphopoiesis in interleukin-7 receptor-deficient mice</article-title>. <source>Cell</source>. (<year>1997</year>) <volume>89</volume>(<issue>7</issue>):<page-range>1033&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80291-3</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maraskovsky</surname> <given-names>E</given-names>
</name>
<name>
<surname>O'Reilly</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Teepe</surname> <given-names>M</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Peschon</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Strasser</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Bcl-2 can rescue t lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice</article-title>. <source>Cell</source>. (<year>1997</year>) <volume>89</volume>(<issue>7</issue>):<page-range>1011&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80289-5</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniels</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Luera</surname> <given-names>D</given-names>
</name>
<name>
<surname>Teixeiro</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>NF&#x3ba;B signaling in T cell memory</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1129191</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boothby</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Mora</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Scherer</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Brockman</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Ballard</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Perturbation of the t lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB</article-title>. <source>J Exp Med</source>. (<year>1997</year>) <volume>185</volume>(<issue>11</issue>):<page-range>1897&#x2013;907</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.185.11.1897</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiToro</surname> <given-names>D</given-names>
</name>
<name>
<surname>Harbour</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Bando</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Benavides</surname> <given-names>G</given-names>
</name>
<name>
<surname>Witte</surname> <given-names>S</given-names>
</name>
<name>
<surname>Laufer</surname> <given-names>VA</given-names>
</name>
<etal/>
</person-group>. <article-title>Insulin-like growth factors are key regulators of t helper 17 regulatory T cell balance in autoimmunity</article-title>. <source>Immunity</source>. (<year>2020</year>) <volume>52</volume>(<issue>4</issue>):<fpage>650</fpage>&#x2013;<lpage>667.e610</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2020.03.013</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khader</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Gaffen</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Kolls</surname> <given-names>JK</given-names>
</name>
</person-group>. <article-title>Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa</article-title>. <source>Mucosal Immunol</source>. (<year>2009</year>) <volume>2</volume>(<issue>5</issue>):<page-range>403&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mi.2009.100</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McArdel</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Terhorst</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>AH</given-names>
</name>
</person-group>. <article-title>Roles of CD48 in regulating immunity and tolerance</article-title>. <source>Clin Immunol</source>. (<year>2016</year>) <volume>164</volume>:<fpage>10</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clim.2016.01.008</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watkinson</surname> <given-names>F</given-names>
</name>
<name>
<surname>Nayar</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Rani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sakellariou</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Elhage</surname> <given-names>O</given-names>
</name>
<name>
<surname>Papaevangelou</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-15 upregulates telomerase expression and potently increases proliferative capacity of NK, NKT-like, and CD8 T cells</article-title>. <source>Front Immunol</source>. (<year>2021</year>), <elocation-id>11</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.594620</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shenoy</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Kirschnek</surname> <given-names>S</given-names>
</name>
<name>
<surname>H&#xe4;cker</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>IL-15 regulates bcl-2 family members bim and mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells</article-title>. <source>Eur J Immunol</source>. (<year>2014</year>) <volume>44</volume>(<issue>8</issue>):<page-range>2500&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201344238</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulton</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Hamilton</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Best</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Goldrath</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>The TCR's sensitivity to self peptide-MHC dictates the ability of naive CD8(+) T cells to respond to foreign antigens</article-title>. <source>Nat Immunol</source>. (<year>2015</year>) <volume>16</volume>(<issue>1</issue>):<page-range>107&#x2013;17</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3043</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azzam</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Grinberg</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shores</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Love</surname> <given-names>PE</given-names>
</name>
</person-group>. <article-title>CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity</article-title>. <source>J Exp Med</source>. (<year>1998</year>) <volume>188</volume>(<issue>12</issue>):<page-range>2301&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.188.12.2301</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stillwell</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bierer</surname> <given-names>BE</given-names>
</name>
</person-group>. <article-title>T cell signal transduction and the role of CD7 in costimulation</article-title>. <source>Immunol Res</source>. (<year>2001</year>) <volume>24</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1385/IR:24:1:31</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aandahl</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Sandberg</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Beckerman</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Task&#xe9;n</surname> <given-names>K</given-names>
</name>
<name>
<surname>Moretto</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Nixon</surname> <given-names>DF</given-names>
</name>
</person-group>. <article-title>CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets</article-title>. <source>J Immunol</source>. (<year>2003</year>) <volume>170</volume>(<issue>5</issue>):<page-range>2349&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.170.5.2349</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pita-L&#xf3;pez</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Pera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Solana</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Adaptive memory of human NK-like CD8+ t-cells to aging, and viral and tumor antigens</article-title>. <source>Front Immunol</source>. (<year>2016</year>) <volume>7</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2016.00616</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunturi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Forman</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The role of CD94/NKG2 in innate and adaptive immunity</article-title>. <source>Immunol Res</source>. (<year>2004</year>) <volume>30</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1385/IR:30:1:029</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamieson</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Diefenbach</surname> <given-names>A</given-names>
</name>
<name>
<surname>McMahon</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>N</given-names>
</name>
<name>
<surname>Carlyle</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Raulet</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>The role of the NKG2D immunoreceptor in immune cell activation and natural killing</article-title>. <source>Immunity</source>. (<year>2002</year>) <volume>17</volume>(<issue>1</issue>):<fpage>19</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(02)00333-3</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wensveen</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Jelen&#x10d;i&#x107;</surname> <given-names>V</given-names>
</name>
<name>
<surname>Poli&#x107;</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>NKG2D: A master regulator of immune cell responsiveness</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>441</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.00441</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ron-Harel</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ghergurovich</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Notarangelo</surname> <given-names>G</given-names>
</name>
<name>
<surname>LaFleur</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Tsubosaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>AH</given-names>
</name>
<etal/>
</person-group>. <article-title>T cell activation depends on extracellular alanine</article-title>. <source>Cell Rep</source>. (<year>2019</year>) <volume>28</volume>(<issue>12</issue>):<fpage>3011</fpage>&#x2013;<lpage>3021.e3014</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.034</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Du</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunization with autologous T cells enhances <italic>in vivo</italic> anti-tumor immune responses accompanied by up-regulation of GADD45beta</article-title>. <source>Cell Res</source>. (<year>2006</year>) <volume>16</volume>(<issue>8</issue>):<page-range>702&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1038/sj.cr.7310083</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ferrandino</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Flavell</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells</article-title>. <source>Nat Immunol</source>. (<year>2004</year>) <volume>5</volume>(<issue>1</issue>):<fpage>38</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni1020</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinarello</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Novick</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kaplanski</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Interleukin-18 and IL-18 binding protein</article-title>. <source>Front Immunol</source>. (<year>2013</year>) <volume>4</volume>:<elocation-id>289</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2013.00289</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Ouyang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production</article-title>. <source>Nat Immunol</source>. (<year>2001</year>) <volume>2</volume>(<issue>2</issue>):<page-range>157&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1038/84264</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Embgenbroich</surname> <given-names>M</given-names>
</name>
<name>
<surname>Burgdorf</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Current concepts of antigen cross-presentation</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01643</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kao</surname> <given-names>PN</given-names>
</name>
</person-group>. <article-title>NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function</article-title>. <source>Exp Cell Res</source>. (<year>2005</year>) <volume>305</volume>(<issue>2</issue>):<page-range>312&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.yexcr.2004.12.030</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lelliott</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Ramsbottom</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Dowling</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Shembrey</surname> <given-names>C</given-names>
</name>
<name>
<surname>Noori</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kearney</surname> <given-names>CJ</given-names>
</name>
<etal/>
</person-group>. <article-title>NKG7 enhances CD8+ T cell synapse efficiency to limit inflammation</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>931630</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.931630</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname> <given-names>KHG</given-names>
</name>
</person-group>. <article-title>IL-17 and IL-17-producing cells in protection versus pathology</article-title>. <source>Nat Rev Immunol</source>. (<year>2023</year>) <volume>23</volume>(<issue>1</issue>):<fpage>38</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-022-00746-9</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zell</surname> <given-names>T</given-names>
</name>
<name>
<surname>Khoruts</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ingulli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bonnevier</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Mueller</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen <italic>in vivo</italic>
</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2001</year>) <volume>98</volume>(<issue>19</issue>):<page-range>10805&#x2013;10</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.191567898</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Di</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Deltex-1 is indispensible for the IL-6 and TGF-&#x3b2; treatment-triggered differentiation of Th17 cells</article-title>. <source>Cell Immunol</source>. (<year>2020</year>) <volume>356</volume>:<fpage>104176</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellimm.2020.104176</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname> <given-names>A</given-names>
</name>
<name>
<surname>Banks</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Nawijn</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>XP</given-names>
</name>
<name>
<surname>Rothman</surname> <given-names>PB</given-names>
</name>
</person-group>. <article-title>Cutting edge: Suppressor of cytokine signaling 3 inhibits activation of NFATp</article-title>. <source>J Immunol</source>. (<year>2002</year>) <volume>168</volume>(<issue>9</issue>):<page-range>4277&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.168.9.4277</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avram</surname> <given-names>D</given-names>
</name>
<name>
<surname>Califano</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases</article-title>. <source>J Immunol</source>. (<year>2014</year>) <volume>193</volume>(<issue>5</issue>):<page-range>2059&#x2013;65</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1400930</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanvalkenburgh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Albu</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Bapanpally</surname> <given-names>C</given-names>
</name>
<name>
<surname>Casanova</surname> <given-names>S</given-names>
</name>
<name>
<surname>Califano</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Critical role of Bcl11b in suppressor function of t regulatory cells and prevention of inflammatory bowel disease</article-title>. <source>J Exp Med</source>. (<year>2011</year>) <volume>208</volume>(<issue>10</issue>):<page-range>2069&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20102683</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Califano</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sweeney</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Le</surname> <given-names>H</given-names>
</name>
<name>
<surname>VanValkenburgh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yager</surname> <given-names>E</given-names>
</name>
<name>
<surname>O'Connor</surname> <given-names>W</given-names>
<suffix>Jr.</suffix>
</name>
<etal/>
</person-group>. <article-title>Diverting t helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis</article-title>. <source>J Clin Invest.</source>. (<year>2014</year>) <volume>124</volume>(<issue>1</issue>):<page-range>174&#x2013;87</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI70103</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latchman</surname> <given-names>YE</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chernova</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Klemm</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2004</year>) <volume>101</volume>(<issue>29</issue>):<page-range>10691&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0307252101</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitmire</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Eam</surname> <given-names>B</given-names>
</name>
<name>
<surname>Whitton</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Mice deficient in stem cell antigen-1 (Sca1, ly-6A/E) develop normal primary and memory CD4+ and CD8+ t-cell responses to virus infection</article-title>. <source>Eur J Immunol</source>. (<year>2009</year>) <volume>39</volume>(<issue>6</issue>):<page-range>1494&#x2013;504</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.200838959</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Upadhyay</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Emerging role of lymphocyte antigen-6 family of genes in cancer and immune cells</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>819</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00819</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaech</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Hemby</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kersh</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Molecular and functional profiling of memory CD8 T cell differentiation</article-title>. <source>Cell</source>. (<year>2002</year>) <volume>111</volume>(<issue>6</issue>):<page-range>837&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0092-8674(02)01139-X</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Tomassian</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bruhn</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Poirier</surname> <given-names>F</given-names>
</name>
<name>
<surname>Miceli</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>182</volume>(<issue>9</issue>):<page-range>5283&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0803811</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borthwick</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Lowdell</surname> <given-names>M</given-names>
</name>
<name>
<surname>Salmon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Akbar</surname> <given-names>AN</given-names>
</name>
</person-group>. <article-title>Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type i IFN, and increases susceptibility to activation-induced apoptosis</article-title>. <source>Int Immunol</source>. (<year>2000</year>) <volume>12</volume>(<issue>7</issue>):<page-range>1005&#x2013;13</page-range>. doi: <pub-id pub-id-type="doi">10.1093/intimm/12.7.1005</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunkle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dzhagalov</surname> <given-names>I</given-names>
</name>
<name>
<surname>He</surname> <given-names>YW</given-names>
</name>
</person-group>. <article-title>Cytokine-dependent and cytokine-independent roles for mcl-1: genetic evidence for multiple mechanisms by which mcl-1 promotes survival in primary t lymphocytes</article-title>. <source>Cell Death Dis</source>. (<year>2011</year>) <volume>2</volume>(<issue>10</issue>):<fpage>e214</fpage>. doi: <pub-id pub-id-type="doi">10.1038/cddis.2011.95</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Neldner</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>J</given-names>
</name>
<name>
<surname>Craig</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Suresh</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Mcl-1 regulates effector and memory CD8 t-cell differentiation during acute viral infection</article-title>. <source>Virology</source>. (<year>2016</year>) <volume>490</volume>:<fpage>75</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virol.2016.01.008</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroczek</surname> <given-names>R</given-names>
</name>
<name>
<surname>Henn</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells</article-title>. <source>Front Immunol</source>. (<year>2012</year>) <volume>3</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2012.00014</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kitahata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kawabata</surname> <given-names>F</given-names>
</name>
<name>
<surname>Kamei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Takamura</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A highly active form of XCL1/Lymphotactin functions as an effective adjuvant to recruit cross-presenting dendritic cells for induction of effector and memory CD8+ T cells</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02775</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knosp</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Regulation of CD4+ t-cell polarization by suppressor of cytokine signalling proteins</article-title>. <source>Immunology</source>. (<year>2012</year>) <volume>135</volume>(<issue>2</issue>):<page-range>101&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2567.2011.03520.x</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Lo</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>ST</given-names>
</name>
<etal/>
</person-group>. <article-title>Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy</article-title>. <source>Immunity</source>. (<year>2009</year>) <volume>31</volume>(<issue>1</issue>):<fpage>72</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2009.04.017</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingram</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Zajac</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections</article-title>. <source>PloS Pathog</source>. (<year>2011</year>) <volume>7</volume>(<issue>9</issue>):<elocation-id>e1002273</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002273</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Shwartz</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ortiz-Lopez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Y-c</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Treg cells require Izumo1R to regulate &#x3b3;&#x3b4;T cell-driven inflammation in the skin</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2023</year>) <volume>120</volume>(<issue>14</issue>):<elocation-id>e2221255120</elocation-id>.</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lingel</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wissing</surname> <given-names>J</given-names>
</name>
<name>
<surname>Arra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schanze</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lienenklaus</surname> <given-names>S</given-names>
</name>
<name>
<surname>Klawonn</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>CTLA-4-mediated posttranslational modifications direct cytotoxic t-lymphocyte differentiation</article-title>. <source>Cell Death Differ</source>. (<year>2017</year>) <volume>24</volume>(<issue>10</issue>):<page-range>1739&#x2013;49</page-range>. doi: <pub-id pub-id-type="doi">10.1038/cdd.2017.102</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macian</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>NFAT proteins: key regulators of t-cell development and function</article-title>. <source>Nat Rev Immunol</source>. (<year>2005</year>) <volume>5</volume>(<issue>6</issue>):<page-range>472&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri1632</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giampaolo</surname> <given-names>S</given-names>
</name>
<name>
<surname>W&#xf3;jcik</surname> <given-names>G</given-names>
</name>
<name>
<surname>Klein-Hessling</surname> <given-names>S</given-names>
</name>
<name>
<surname>Serfling</surname> <given-names>E</given-names>
</name>
<name>
<surname>Patra</surname> <given-names>AK</given-names>
</name>
</person-group>. <article-title>B cell development is critically dependent on NFATc1 activity</article-title>. <source>Cell Mol Immunol</source>. (<year>2019</year>) <volume>16</volume>(<issue>5</issue>):<page-range>508&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41423-018-0052-9</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pata</surname> <given-names>S</given-names>
</name>
<name>
<surname>Surinkaew</surname> <given-names>S</given-names>
</name>
<name>
<surname>Takheaw</surname> <given-names>N</given-names>
</name>
<name>
<surname>Laopajon</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chuensirikulchai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kasinrerk</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Differential CD147 functional epitopes on distinct leukocyte subsets</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>704309</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.704309</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solstad</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bains</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Landskron</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aandahl</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Thiede</surname> <given-names>B</given-names>
</name>
<name>
<surname>Task&#xe9;n</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells</article-title>. <source>Blood</source>. (<year>2011</year>) <volume>118</volume>(<issue>19</issue>):<page-range>5141&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2011-02-339242</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tripathi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mattner</surname> <given-names>J</given-names>
</name>
<name>
<surname>Phelan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sproles</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct roles of Cdc42 in thymopoiesis and effector and memory T cell differentiation</article-title>. <source>PloS One</source>. (<year>2011</year>) <volume>6</volume>(<issue>3</issue>):<elocation-id>e18002</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0018002</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oda</surname> <given-names>H</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sakai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kitahara</surname> <given-names>S</given-names>
</name>
<name>
<surname>Patrick</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Azuma</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Rac1-mediated bcl-2 induction is critical in antigen-induced CD4 single-positive differentiation of a CD4+CD8+ immature thymocyte line</article-title>. <source>J Leukoc Biol</source>. (<year>2007</year>) <volume>81</volume>(<issue>2</issue>):<page-range>500&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1189/jlb.1005585</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>ZBP1: A powerful innate immune sensor and double-edged sword in host immunity</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>(<issue>18</issue>):<fpage>10224</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms231810224</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossy</surname> <given-names>J</given-names>
</name>
<name>
<surname>Williamson</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Gaus</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>How does the kinase lck phosphorylate the T cell receptor? spatial organization as a regulatory mechanism</article-title>. <source>Front Immunol</source>. (<year>2012</year>) <volume>3</volume>:<elocation-id>167</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2012.00167</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Merwe</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>A subtle role for CD2 in T cell antigen recognition</article-title>. <source>J Exp Med</source>. (<year>1999</year>) <volume>190</volume>(<issue>10</issue>):<page-range>1371&#x2013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.190.10.1371</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname> <given-names>E</given-names>
</name>
<name>
<surname>Araki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hashimoto</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of PD-1 during effector CD8 T cell differentiation</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2018</year>) <volume>115</volume>(<issue>18</issue>):<page-range>4749&#x2013;54</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1718217115</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharpe</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Pauken</surname> <given-names>KE</given-names>
</name>
</person-group>. <article-title>The diverse functions of the PD1 inhibitory pathway</article-title>. <source>Nat Rev Immunol</source>. (<year>2018</year>) <volume>18</volume>(<issue>3</issue>):<page-range>153&#x2013;67</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri.2017.108</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>ALG-2 couples T cell activation and apoptosis by regulating proteasome activity and influencing MCL1 stability</article-title>. <source>Cell Death Dis</source>. (<year>2020</year>) <volume>11</volume>(<issue>1</issue>):<fpage>5</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-019-2199-4</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ablamunits</surname> <given-names>V</given-names>
</name>
<name>
<surname>Henegariu</surname> <given-names>O</given-names>
</name>
<name>
<surname>Preston-Hurlburt</surname> <given-names>P</given-names>
</name>
<name>
<surname>Herold</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody</article-title>. <source>Eur J Immunol</source>. (<year>2011</year>) <volume>41</volume>(<issue>7</issue>):<page-range>1832&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201041258</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lisiero</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Tejera</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Neldner</surname> <given-names>BT</given-names>
</name>
<name>
<surname>Warrick</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Wuerzberger-Davis</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>I&#x3ba;B&#x3b1; nuclear export enables 4-1BB-Induced cRel activation and IL-2 production to promote CD8 T cell immunity</article-title>. <source>J Immunol</source>. (<year>2020</year>) <volume>205</volume>(<issue>6</issue>):<page-range>1540&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.2000039</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yigit</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ten Hacken</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Bhan</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Suarez-Fueyo</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>SLAMF6 as a regulator of exhausted CD8(+) T cells in cancer</article-title>. <source>Cancer Immunol Res</source>. (<year>2019</year>) <volume>7</volume>(<issue>9</issue>):<page-range>1485&#x2013;96</page-range>. doi: <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-18-0664</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Readinger</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Mueller</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Venegas</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Horai</surname> <given-names>R</given-names>
</name>
<name>
<surname>Schwartzberg</surname> <given-names>PL</given-names>
</name>
</person-group>. <article-title>Tec kinases regulate t-lymphocyte development and function: new insights into the roles of itk and Rlk/Txk</article-title>. <source>Immunol Rev</source>. (<year>2009</year>) <volume>228</volume>(<issue>1</issue>):<fpage>93</fpage>&#x2013;<lpage>114</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00757.x</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Eno</surname> <given-names>CO</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>White</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ uptake</article-title>. <source>J Biol Chem</source>. (<year>2013</year>) <volume>288</volume>(<issue>27</issue>):<page-range>19870&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M112.448290</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosentino</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hertlein</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jenner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dellmann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gojkovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pe&#xf1;a-Blanco</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation</article-title>. <source>Mol Cell</source>. (<year>2022</year>) <volume>82</volume>(<issue>5</issue>):<fpage>933</fpage>&#x2013;<lpage>949.e939</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2022.01.008</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Wherry</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Goldrath</surname> <given-names>AW</given-names>
</name>
</person-group>. <article-title>Molecular regulation of effector and memory T cell differentiation</article-title>. <source>Nat Immunol</source>. (<year>2014</year>) <volume>15</volume>(<issue>12</issue>):<page-range>1104&#x2013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3031</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seok</surname> <given-names>J</given-names>
</name>
<name>
<surname>Warren</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Cuenca</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Mindrinos</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Baker</surname> <given-names>HV</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic responses in mouse models poorly mimic human inflammatory diseases</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2013</year>) <volume>110</volume>(<issue>9</issue>):<page-range>3507&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1222878110</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Miyakawa</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Genomic responses in mouse models greatly mimic human inflammatory diseases</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2015</year>) <volume>112</volume>(<issue>4</issue>):<page-range>1167&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1401965111</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>